Satisfaction and Treatment Burden Among Early Adopters of Long-Acting Injectable Cabotegravir-Rilpivirine With and Without Viremia in Three U.S. Ryan White Clinics

Clicks: 18
ID: 329172
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #189 of 316 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 316 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Among underserved people with HIV with a median of one year of long-acting cabotegravir-rilpivirine use, including those starting with viremia due to adherence challenges, we found higher satisfaction and lower treatment burden compared to daily oral ART, although nearly half preferred another dosing modality and/or a longer dosing interval.
Reference Key
openalex_W7213611823 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Katerina Christopoulos, Alex Beckert, Caleb McCracken, Kaylin Dance, Sophie Plotkin, Lauren F. Collins, Moira McNulty, Matthew D. Hickey, Mallory O. Johnson, Aaloke Mody, Xavier A. Erguera, Kimberly A. Koester, Geoffroy Liégeon, Jorge D. Salazar, José I. Gutierrez, Janet Grochowski, Samantha E. Dilworth, Torsten B. Neilands, Elizabeth T Montogomery, Jonathan Colasanti
Are you one of these authors? Claim your profile
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag559
URL
https://doi.org/10.1093/ofid/ofag559
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.